![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Parkinson's Disease |
|
Free Subscription
1 Exp Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Parkinson's Disease is free of charge.
Progress in animal models of rapid eye movement sleep behavior disorder:
Characteristics and applications.
Exp Neurol. 2026;403:115823.
PubMed
Abstract available
The social cost of facial bradykinesia: a scoping review of interpersonal
outcomes related to Parkinsonian hypomimia.
J Neural Transm (Vienna). 2026 Jun 6. doi: 10.1007/s00702-026-03190.
PubMed
Abstract available
Exploring the relationship between interoception and mental body representation
in Parkinson's disease.
J Neural Transm (Vienna). 2026 Jun 6. doi: 10.1007/s00702-026-03194.
PubMed
Abstract available
A Biological Framework for Parkinson's Disease: Advances in alpha-Synuclein-Centered
Biomarkers and Staging.
J Neurochem. 2026;170:e70491.
PubMed
Abstract available
Rare-Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside
Metabolism in Parkinson's Disease.
Mov Disord. 2026 Jun 10. doi: 10.1002/mds.70391.
PubMed
Abstract available
Spatiotemporal Progression Patterns of Striatal Dopamine Depletion and Cerebral
Hypoperfusion in Parkinson's Disease.
Mov Disord. 2026 Jun 8. doi: 10.1002/mds.70398.
PubMed
Abstract available
Challenges of Pain in Parkinson's Disease: Results from the OCEAN Study.
Mov Disord. 2026 Jun 8. doi: 10.1002/mds.70390.
PubMed
Abstract available
Associations Between Cumulative Head Trauma and Self-Reported Parkinsonism and
Parkinson's Disease in Former Soccer Players.
Mov Disord. 2026 Jun 7. doi: 10.1002/mds.70380.
PubMed
Abstract available
Dual-target gene therapy in Parkinson's disease: a multicenter phase 1 trial.
Nat Med. 2026 Jun 10. doi: 10.1038/s41591-026-04436.
PubMed
Abstract available
N-terminal acetylation reduces synuclein pathology in models of Parkinson's
disease.
Neurobiol Dis. 2026 Jun 11:107485. doi: 10.1016/j.nbd.2026.107485.
PubMed
Abstract available
MRI mapping of nigrostriatal pathway degeneration in early-stage Parkinson's
disease.
Neurobiol Dis. 2026 Jun 10:107479. doi: 10.1016/j.nbd.2026.107479.
PubMed
Abstract available
Shared and symptom-specific local field potential spectral signatures of motor
symptoms in Parkinson's disease.
Neurobiol Dis. 2026 Jun 5:107472. doi: 10.1016/j.nbd.2026.107472.
PubMed
Abstract available
Reach of Palliative Care in Parkinson Disease: Progress and Gaps After a National
Team-Based Implementation Project.
Neurol Clin Pract. 2026;16:e200628.
PubMed
Abstract available
Drivers of Rising Prevalence in Major Motor Neurodegenerative Diseases: Temporal
Trends in Sweden and France (2003-2022).
Neurology. 2026;107:e218072.
PubMed
Abstract available
Thank you for your interest in scientific medicine.